home / stock / drug / drug news


DRUG News and Press, Bright Minds Biosciences Inc.

Stock Information

Company Name: Bright Minds Biosciences Inc.
Stock Symbol: DRUG
Market: NASDAQ
Website: brightmindsbio.com

Menu

DRUG DRUG Quote DRUG Short DRUG News DRUG Articles DRUG Message Board
Get DRUG Alerts

News, Short Squeeze, Breakout and More Instantly...

DRUG - Expected US Company Earnings on Thursday, February 12th, 2026

Baxter International Inc. (BAX) is expected to report $0.53 for Q4 2025 Nova Ltd. (NVMI) is expected to report $1.94 for Q4 2025 West Pharmaceutical Services Inc. (WST) is expected to report $1.83 for Q4 2025 Universal Logistics Holdings Inc. (ULH) is expected to report $-0.05 for Q4 ...

DRUG - Expected earnings - Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. (DRUG) is expected to report $-0.98 for Q1 2026

DRUG - DRUG - Historical Price Movements Surrounding Earnings

2026-02-11 17:39:17 ET Bright Minds Biosciences Inc. (DRUG) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.26%. The average open to low on the day of earnings was -3.81%. The average ...

DRUG - DRUG - Historical Earnings Price Analysis

2026-02-11 17:34:19 ET Bright Minds Biosciences Inc. (DRUG) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in DRUG stock price following earnings has averaged ±1.41% , with a median of 0...

DRUG - Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“ Bright Minds ” or the “ Company ”) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “ Com...

DRUG - Bright Minds prices $175M stock offering

2026-01-08 02:29:20 ET More on Bright Minds Biosciences Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating Bright Minds Biosciences launches $100 million public offering Bright Minds gains on mid-stage trial win for lead asset ...

DRUG - Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“ Bright Minds ” or the “ Company ”) announces the pricing of its previously announced public offering of 1,945,000 common shares in the capital of the Company (the ...

DRUG - Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating

2026-01-07 15:00:21 ET The last time I spoke about Bright Minds Biosciences ( DRUG ) it was with respect to an article entitled " Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101 ". With respect to this article, I noted that this com...

DRUG - Biggest stock movers Wednesday: VTYX, MBLY, and more

2026-01-07 05:01:16 ET More on related stocks: Mobileye Global Inc. (MBLY) Presents at UBS Global Industrials and Transportation Conference Transcript Mobileye: ADAS Thrives While Advanced Products Stuck In Neutral, Still Undervalued HIVE Digital: 'Cheap' Despite Exp...

DRUG - Bright Minds Biosciences launches $100 million public offering

2026-01-06 16:04:47 ET More on Bright Minds Biosciences Inc. Bright Minds gains on mid-stage trial win for lead asset Seeking Alpha’s Quant Rating on Bright Minds Biosciences Inc. Historical earnings data for Bright Minds Biosciences Inc. Financial inf...

Next 10